Suppr超能文献

α-去甲肾上腺素能激动剂可促使小鼠产生僵住症。

Alpha noradrenergic agonists promote catalepsy in the mouse.

作者信息

Sukul N C, Cherian L, Klemm W R

机构信息

Department of Veterinary Anatomy, Texas A&M University, College Station 77843.

出版信息

Pharmacol Biochem Behav. 1988 Sep;31(1):87-91. doi: 10.1016/0091-3057(88)90316-4.

Abstract

Alpha adrenergic receptors are important in motor control. Adrenergic drugs reportedly modulate the catalepsy caused by other agents, such as opiates and neuroleptics. We tested a variety of adrenergic agonists and blockers in a nondrug, mouse model of catalepsy. A major cataleptic effect was produced by both alpha agonists, phenylephrine (0.5 to 3 mg/kg, IP) and clonidine (0.5 to 2 mg/kg), and this catalepsy was antagonized by pretreatment with both of the respective antagonists, phenoxybenzamine (alpha-1) and yohimbine (alpha-2) (p less than 0.0001). The mixed beta agonist, isoproterenol (2 mg/kg), appeared to have a minor cataleptic effect, and this was abolished by beta antagonist. Open-field locomotor scores during the same treatments revealed that catalepsy and hypokinesia are dissociable.

摘要

α肾上腺素能受体在运动控制中很重要。据报道,肾上腺素能药物可调节由其他药物(如阿片类药物和抗精神病药物)引起的僵住症。我们在一个非药物性的小鼠僵住症模型中测试了多种肾上腺素能激动剂和阻滞剂。α激动剂去氧肾上腺素(0.5至3毫克/千克,腹腔注射)和可乐定(0.5至2毫克/千克)均产生了主要的僵住症效应,并且这种僵住症可被各自的拮抗剂酚苄明(α-1)和育亨宾(α-2)预处理所拮抗(p小于0.0001)。混合β激动剂异丙肾上腺素(2毫克/千克)似乎有轻微的僵住症效应,并且这种效应被β拮抗剂消除。相同处理期间的旷场运动评分显示,僵住症和运动减退是可分离的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验